Page results
-
Information about the council of governors at University College London Hospitals NHS Foundation Trust
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
I would like to make a payment to UCLH, I have a query about reclaiming expenses for treatment or transport at University College Hospital or I have a query about expenses for treatment or transport at Queen Square (NHNN/RLHIM)
-
Exam guidance for children and young people with type 1 diabetes
-
How to refer to infectious and tropical diseases.
-
As with any form of pain management, different resources or techniques will suit different people. Please remember that you may need to try out more than one book, CD or website before you find…
-
We provide a specialist clinic for people who either have, or who are at risk of developing Huntington’s disease (HD), and their families and carers. We see people for the following reasons: To…
-
We are a specialist Children and Young People's (CYP) Endocrinology Service. We also have access to the specialist adolescent psychology service, play specialists, and safeguarding team and are supported by a team of admin staff.
-
UCLH has one of the most extensive portfolios of adolescent services in the UK.
File results
-
FOI/2023/0399 - Patient deaths while waiting to receive planned care/ patients waiting more than 18 weeks - 2022
-
FOI/2023/0401 - Patient treatments for brain tumour from 2018-2022
-
FOI/2023/0402 - Migraine treatment/ medication
-
FOI/2023/0403 - Patients detained under the Mental Health Act - 2018-2023
-
FOI/2023/0410 - Clinical systems at the Trust
-
FOI/2023/0413 - Care hotels for patients used/ booked by Trust - 2022/23
-
FOI/2023/0414 - Operation cancelled for non-clinical reasons - 2018-2022
-
FOI/2023/0415 - Contact details for senior staff at Estates and Facilities
-
FOI/2023/0416 - Treatments for non-small cell lung cancer
-
FOI/2023/0422 - Renal cell treatment for carcinoma and melanoma